Education
About Us
Working with TipRanks
Follow Us
John Greene Insider Profile
4 Followers
John Greene, See Remarks at Willis Towers Watson, holds 0.00 shares in Discover Financial Services (Ticker: DFS), holds 7.00K shares in Crispr Therapeutics AG (Ticker: CRSP), holds 0.00 shares in Bioverativ Inc (Ticker: BIVV).
Profitable Transactions
3 out of 3 Profitable Transactions
Average Return
+23.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that John Greene holds in companies
Most Profitable Insider Trade
The most profitable trade made by John Greene
John Greene's Trading History
Willis Towers Watson
Jan 06, 2016
See Remarks
Uninformative Buy
―
$4.60M
Bioverativ Inc
Mar 08, 2018
―
Uninformative Sell
―
$0.00
Crispr Therapeutics AG
Feb 28, 2025
Director
Informative Buy
313.88K
$476.98K
Discover Financial Services
May 19, 2025
―
Uninformative Sell
―
$0.00
List of latest transactions for each holding click on a transaction to see John Greene's performance on stock
You May Also Like
John Greene insider profile FAQ
What is the percentage of profitable transactions made by John Greene?
The percentage of profitable transactions made by John Greene is 100%.
What is the average return per transaction made by John Greene?
The average return per transaction made by John Greene is 23.60%.
What stocks does John Greene hold?
John Greene holds: WTW, BIVV, CRSP, DFS stocks.
What was John Greene’s latest transaction?
John Greene latest transaction was an Uninformative Sell of ―.
What was John Greene's most profitable transaction?
John Greene’s most profitable transaction was an Informative Buy of CRSP stock on February 28, 2025. The return on the trade was 48.20%.
What is John Greene's role in Willis Towers Watson?
John Greene's role in Willis Towers Watson is See Remarks.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.